Location History:
- Rochester, NY (US) (1981 - 1999)
- Galveston, TX (US) (2006 - 2017)
Company Filing History:
6 out of 5,469 
3 out of 975 
1 out of 444 Years Active: 1981-2017
Title: Innovations of James F Leary
Introduction
James F Leary is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleoside aptamers. With a total of 10 patents to his name, his work has had a profound impact on medical research and treatment methodologies.
Latest Patents
One of his latest patents is titled "Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors." This invention includes compositions and methods for creating a combinatorial library to identify modified thioaptamers that bind to and influence the immune response of host animals. The patent also addresses transcription factors such as IL-6, NF-κB, and AP-1. Additionally, it provides compositions and methods for treating viral infections, as well as vaccines and vaccine adjuvants that modify host immune responses.
Career Highlights
James has worked with prestigious institutions, including the University of Texas System and the University of Rochester. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Mark A Corio and Scott R McLaughlin. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.
Conclusion
James F Leary's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments and therapies that enhance immune responses and combat viral infections.